January 30, 2012
Domain Therapeutics awarded grant from The Michael J. Fox Foundation for the development of novel mGluR3 PAM compounds to treat Parkinson's disease
more... view the .pdf

January 17, 2011
Domain Therapeutics and Merck Serono Announce an Agreement to Develop Drugs for Parkinson’s Disease
more... view the .pdf

November 4, 2009
Domain Therapeutics announces successful completion of the first milestone in its Research Agreement with Takeda Pharmaceutical...
more… view the .pdf

December 15, 2008
Domain Therapeutics raises EUR 2.11M...
more… view the .pdf

December 1, 2008
Domain Therapeutics, a new name in GPCR drug discovery...
more… view the .pdf